The Pediatric Clinical Core of the Dana Farber Cancer Institute (DFCI) Center for AIDS Research consists of the AIDS Program at Children's Hospital and its affiliations with the Obstetrics Departments at the Brigham and Women's Hospital and the Beth Israel Hospital. Children's Hospital itself is immediately adjacent to the DFCI, connected to it by a bridge. The Children's Hospital AIDS Program (CHAP) is a multidisciplinary unit directed by Dr. McIntosh, the Chief of the Division of Infectious Diseases. The staff includes three full-time members of the staff of the Division of Infectious Diseases, M.D. fellows, six nurses, three social workers, a part-time pharmacist, administrative and data-handling support, and the HIV clinical laboratory with two technologists. At the Brigham and Women's Hospital staff consists of an obstetrician, Dr. Ruth Tuomala, a nurse and pharmacist, all of whom are dedicated part time to the Program. The CHAP follows and consults on more than half the children with HIV infection in Massachusetts, Rhode Island, New Hampshire, and Maine, and draws on a group of experienced consultants in multiple disciplines, including immunology, gastroenterology and nutrition, neurology, pulmonology, cardiology, psychology and development, hematology and others. In addition, through both the ACTU and WITS, there are very close connections with units at Boston City Hospital and the University of Massachusetts in Worcester, MA. The present research program of CHAP is supported primarily through the AIDS Clinical Trials Group of NIAID as well as the Women and Infants Transmission Study. Both are supported for the next fours years under grants to Dr. McIntosh (ACTG) and Dr. Tuomala (WITS). HIV-directed laboratory researchers in the Division of Infectious Diseases at Children's Hospital are also supported through Foundation and NIH grants.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI028691-09
Application #
6234950
Study Section
Project Start
1997-08-01
Project End
1998-07-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
9
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Liu, Songtao; Fleysher, Roman; Fleysher, Lazar et al. (2010) Brain metabolites B1-corrected proton T1 mapping in the rhesus macaque at 3 T. Magn Reson Med 63:865-71
Liu, Songtao; Gonen, Oded; Fleysher, Roman et al. (2009) Metabolite proton T(2) mapping in the healthy rhesus macaque brain at 3 T. Magn Reson Med 62:1292-9
Ratai, Eva-Maria; Pilkenton, Sarah J; Greco, Jane B et al. (2009) In vivo proton magnetic resonance spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain. BMC Neurosci 10:63
Gonen, Oded; Liu, Songtao; Goelman, Gadi et al. (2008) Proton MR spectroscopic imaging of rhesus macaque brain in vivo at 7T. Magn Reson Med 59:692-9
Ratai, Eva-Maria; Hancu, Ileana; Blezek, Daniel J et al. (2008) Automatic repositioning of MRSI voxels in longitudinal studies: impact on reproducibility of metabolite concentration measurements. J Magn Reson Imaging 27:1188-93
Liu, Songtao; Gonen, Oded; Fleysher, Lazar et al. (2008) Regional metabolite T2 in the healthy rhesus macaque brain at 7T. Magn Reson Med 59:1165-9
Li, Xing; Gold, Bert; O'hUigin, Colm et al. (2007) Unique features of TRIM5alpha among closely related human TRIM family members. Virology 360:419-33
Javanbakht, Hassan; An, Ping; Gold, Bert et al. (2006) Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection. Virology 354:15-27
Diaz-Griffero, Felipe; Li, Xing; Javanbakht, Hassan et al. (2006) Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. Virology 349:300-15
Gonzalez, R Gilberto; Greco, Jane B; He, Julian et al. (2006) New insights into the neuroimmunity of SIV infection by magnetic resonance spectroscopy. J Neuroimmune Pharmacol 1:152-9

Showing the most recent 10 out of 205 publications